HIF1A and colon carcinoma: Importantly, HIF-1α mutant mice harboring MC38 colon carcinoma tumors had a significantly inhibited response to αPD-1 and αCTLA4 combinatorial antibody-based immunotherapy relative to control WT littermates (Figure 4E).